RGT 2.90% 35.5¢ argent biopharma limited

Ann: March Quarterly Activity and Cashflow Report, page-64

  1. 683 Posts.
    lightbulb Created with Sketch. 270
    I agree with you. Hopefully in the next financials we see an even bigger increase in revenue from Derma, payment from Mabsut, and revenue from Cannepil. On top of any other deals that get struck in the meantime.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.